文献速递药物不良反应与药物警戒

瑞士医师与药师对自发 ADR 报告系统的实践、知识与态度调查

Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland.
PubMed 文献 · Br J Clin Pharmacol · 2026-04-17

该研究通过全国性横断面问卷(1108 名医师与药师)评估瑞士自发 ADR 报告现状。53.2% 曾怀疑 ADR,50.7% 至少报告过 1 次;64.6% 知晓报告义务,但 43.1% 认为耗时、24.4% 有法律顾虑;报告行为与年龄增长和培训独立相关;提示需针对性信息宣传与培训。

要点

  • 约半数受访者曾怀疑或报告过 ADR,但报告率仍有提升空间。
  • 43.1% 认为报告耗时,24.4% 存在法律顾虑,是主要障碍。
  • 报告 ADR 与年龄增长和培训独立相关,OR 为 1.28–1.92。

核心结论

  • 医师与药师虽有报告 ADR 的基本意愿,但缺乏具体知识,提示需针对性信息宣传与培训。

研究设计与样本

  • 全国性横断面问卷调查,通过专业协会发放给瑞士医师与药师,共纳入 1108 名参与者(834 名医师、274 名药师),使用 21 条目问卷评估报告实践、知识、态度、信息需求与改进建议,并用多变量回归分析报告习惯与参与者特征的关联。

主要发现

  • 589 名(53.2%)曾怀疑 ADR,562 名(50.7%)至少报告过 1 次 ADR。
  • 999 名(90.2%)不认为报告无意义;716 名(64.6%)知晓报告义务,但 477 名(43.1%)认为报告耗时,270 名(24.4%)有法律顾虑。
  • 587 名(53.0%)表示不缺乏激励,580 名(52.3%)不担心个人数据保护,545 名(49.2%)不担心患者数据保护。
  • 609 名(55.0%)希望获得更清晰的可报告 ADR 指导,648 名(58.5%)对药物警戒培训感兴趣。
  • 报告 ADR 与年龄增长和培训独立相关(OR 介于 1.28 [95% CI: 1.15, 1.42] 与 1.92 [1.32, 2.79] 之间);报告投入 >10 分钟与年龄≥60 岁(OR 1.59 [1.07, 2.38])、培训(OR 1.28 [1.14, 1.45])和药师身份(OR 1.83 [1.34, 2.51])相关。

临床怎么用

  • 临床药师可针对报告耗时与法律顾虑两大障碍,设计简短报告流程与法律免责说明。
  • 对高龄和未培训人员开展药物警戒培训,提升 ADR 报告率。
  • 提供可报告 ADR 的清晰清单与示例,回应 55.0% 受访者的信息需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Reporting adverse drug reactions (ADRs) is essential for detecting drug risks. Despite legal obligations in Switzerland, underreporting remains an issue. This study assessed practice, knowledge and attitudes towards the spontaneous ADR reporting system among physicians and pharmacists. METHODS: A nationwide cross-sectional survey was disseminated via professional associations to physicians and pharmacists in Switzerland. The 21-item questionnaire assessed reporting practice, knowledge, attitudes, information needs and improvement suggestions. Multivariable regression (odds ratios [ORs], 95% confidence intervals [95% CIs]) examined associations between participant characteristics and reporting habits. RESULTS: A total of 1108 participants (834 physicians, 274 pharmacists) were included. ADRs had been suspected by 589 (53.2%), and 562 (50.7%) had reported ≥1 ADR. Most participants rejected the notion that reporting is pointless (999, 90.2%). Although 716 (64.6%) were aware of reporting obligations, 477 (43.1%) perceived reporting as time-consuming and 270 (24.4%) reported legal concerns. About half indicated no lack of incentives (587, 53.0%) and no concerns regarding personal (580, 52.3%) or patient data protection (545, 49.2%). More than half desired clearer guidance on reportable ADRs (609, 55.0%) and 648 (58.5%) expressed interest in pharmacovigilance training. Reporting ADRs was independently associated with increasing age and training (ORs between 1.28 [95% CI: 1.15, 1.42] and 1.92 [1.32, 2.79]), whereas investing >10 min in reporting was associated with age ≥60 (OR 1.59 [1.07, 2.38]), training (OR 1.28 [1.14, 1.45]) and pharmacist status (OR 1.83 [1.34, 2.51]). CONCLUSION: The fundamental willingness to report ADRs despite a simultaneous lack of specific knowledge indicates a need for targeted information campaigns and training opportunities.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Strobel FA, Stammschulte T, Beeler PE, et al. Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland. Br J Clin Pharmacol. 2026. PMID: 41998847. doi:10.1002/bcp.70543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。